Status:
COMPLETED
Efficacy of BIPAMS for Restless Legs Syndrome in Adults With Multiple Sclerosis: A Pilot Study
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Multiple Sclerosis
Restless Legs Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of a 16-week behavioral intervention for increasing physical activity and reducing restless legs syndrome (RLS) severity in persons with multiple ...
Detailed Description
The primary aim of the proposed pilot RCT involves examining the efficacy of a 16-week behavioral intervention for increasing physical activity and reducing RLS severity in persons with MS and RLS. Se...
Eligibility Criteria
Inclusion
- Diagnosis of multiple sclerosis
- Relapse free in the past 30 days
- Positive screen for restless legs syndrome
- Non-active (not engaging in 30 minutes of activity per day on more than 2 days per week in the previous six months)
- Ambulatory without assistance
- Internet and email access
Exclusion
- Diagnosis of radiculopathy, peripheral edema, peripheral neuropathy, iron deficiency (i.e., anemia) renal disease, or diabetes
- Screen at moderate or high risk for undertaking strenuous or maximal exercise
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 23 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04061681
Start Date
January 1 2020
End Date
November 23 2020
Last Update
December 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294